Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of serum soluble triggering receptor expressed on myeloid cells-1 in polycystic ovary syndrome. | Rev Assoc Med Bras (1992) | 2026 | 42820575 | PubTator, text mining | PubMed |
| AI-Designed TREM1-Targeted LYTAC Nanoparticles Reprogram the Neuroimmune Microenvironment in Traumatic Brain Injury. | Adv Sci (Weinh) | 2026 | 42801645 | PubTator, text mining | PubMed |
| ACAT1-Mediated SP1-K694 Lactylation Promotes M1 Macrophage Polarization via TREM1 Transcription in COPD. | Adv Sci (Weinh) | 2026 | 42801550 | PubTator, text mining | PubMed |
| Treatment-Driven Peripheral Blood Transcriptomic Remodeling and Baseline Predictors of ESSDAI and STAR Response to B Cell Therapy in Sjögren's Disease. | Arthritis Rheumatol | 2026 | 42781881 | PubTator, text mining | PubMed |
| Host immune biomarkers associated with infection risk after CAR T-cell therapy. | J Infect | 2026 | 42777835 | PubTator, text mining | PubMed |
| Artificial intelligence-enabled cross-scale integration of traditional Chinese medicine and biomedicine for sepsis: from mechanisms to delivery. | Front Pharmacol | 2026 | 42774781 | PubTator, text mining | PubMed |
| Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer. | Breast Cancer | 2026 | 42766275 | PubTator, text mining | PubMed |
| Exosomes target liver TREM-1 to break the systemic inflammatory cascade and improve spinal cord injury outcomes. | J Orthop Translat | 2026 | 42761472 | PubTator, text mining | PubMed |
| Circulating sTLR4 and sTREM-1 in Knee Osteoarthritis: Associations with Study-Specific MRI-Defined Categories and Disease Burden. | J Clin Med | 2026 | 42739905 | PubTator, text mining | PubMed |
| An analysis of cerebral amyloid angiopathy based on samples from human brain bank. | Front Immunol | 2026 | 42682443 | PubTator, text mining | PubMed |
| Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis. | J Inflamm Res | 2026 | 42670519 | PubTator, text mining | PubMed |
| SHAP-interpretable machine learning integrating exposures and multi-omics reveals immune alterations and biomarkers in COPD-lung cancer comorbidity. | Front Immunol | 2026 | 42630541 | PubTator, text mining | PubMed |
| Evolution of the proinflammatory receptor TREM-1 in mammals reveals signatures of pathogen-driven conflict. | bioRxiv | 2026 | 42620277 | PubTator, text mining | PubMed |
| Generative AI-augmented transcriptomic and microbiome analysis across inflammatory and fibrotic disease states in Crohn's disease. | Front Artif Intell | 2026 | 42614810 | PubTator, text mining | PubMed |
| TREM1 Blockade Reprograms Tumor-Associated Macrophages and Improves Anti-PD-1 Efficacy in Gastric Cancer. | J Gastroenterol Hepatol | 2026 | 42605023 | PubTator, text mining | PubMed |
| Urolithin B ameliorates post-myocardial infarction cardiac dysfunction via TREM1-mediated autophagy activation and pyroptosis inhibition. | Int Immunopharmacol | 2026 | 42594833 | PubTator, text mining | PubMed |
| Phosgene inhalation injury in mice: Modeling human pathophysiology, biomarker discovery, and therapeutic target identification. | Toxicol Appl Pharmacol | 2026 | 42575345 | PubTator, text mining | PubMed |
| Association of the TREM-1-STAT3 Axis With Stroke Severity and Functional Outcomes in Ischemic Stroke: A Prospective Case-Control Study. | Brain Behav | 2026 | 42552903 | PubTator, text mining | PubMed |
| Correction to: Plasma soluble TREM-1 and risk of cardiovascular disease in the population. Results from the Paris Prospective Study III and the CoLaus|PsyCoLaus. | Eur J Prev Cardiol | 2026 | 42525455 | PubTator, text mining | PubMed |
| A New Function of the S100-A4 Protein (Mts1): Mts1 Stimulates the Activation of Cytotoxic Lymphocytes via the TREM-1 Receptor. | Int J Mol Sci | 2026 | 42511702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers